Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sense Biodetection, a UK-based molecular diagnostics technology developer, has raised $15m in a series B extension that brought the round’s total to $65m. Koch Disruptive Technologies (KDT), the investment arm of industrial and chemicals group Koch Industries, led the extension having already led the initial $50m tranche in April 2021, when patient capital fund Cambridge Innovation Capital (CIC), Mercia Asset Management, Earlybird’s Health Tech Fund and Jonathan Milner also invested.

Sandbox VR, the US-based operator of a chain of…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.